2020 多学科共识:哮喘的吸入治疗

2020-11-10 国外呼吸科专家组(统称) Expert Rev Respir Med . 2020 Nov 10;1-10.

哮喘是不同专业的卫生保健人员管理,本文主要目的是针对哮喘的吸入治疗以及初始治疗步骤达成多学科共识。

中文标题:

2020 多学科共识:哮喘的吸入治疗

英文标题:

Multidisciplinary consensus on inhaled therapy in asthma

发布日期:

2020-11-10

简要介绍:

哮喘是不同专业的卫生保健人员管理,本文主要目的是针对哮喘的吸入治疗以及初始治疗步骤达成多学科共识。

相关资料下载:
[AttachmentFileName(sort=1, fileName=2020 多学科共识:哮喘的吸入治疗.pdf)] GetToolGuiderByIdResponse(projectId=1, id=593091c0020130d9, title=2020 多学科共识:哮喘的吸入治疗, enTitle=Multidisciplinary consensus on inhaled therapy in asthma, guiderFrom=Expert Rev Respir Med . 2020 Nov 10;1-10., authorId=0, author=, summary=哮喘是不同专业的卫生保健人员管理,本文主要目的是针对哮喘的吸入治疗以及初始治疗步骤达成多学科共识。, cover=https://img.medsci.cn/20201126/1606321604536_2020535.jpg, journalId=0, articlesId=null, associationId=1219, associationName=国外呼吸科专家组(统称), associationIntro=国外呼吸科专家组(统称), copyright=0, guiderPublishedTime=Tue Nov 10 00:00:00 CST 2020, originalUrl=, linkOutUrl=, content=<div class="one_info2" style="color: #373737;"> <div id="all_content"> <div class="editor_mirror editor_mirror_del"> <p>哮喘是不同专业的卫生保健人员管理,本文主要目的是针对哮喘的吸入治疗以及初始治疗步骤达成多学科共识。</p> </div> </div> </div>, tagList=[TagDto(tagId=441, tagName=哮喘)], categoryList=[CategoryDto(categoryId=12, categoryName=呼吸, tenant=100), CategoryDto(categoryId=85, categoryName=指南&解读, tenant=100), CategoryDto(categoryId=21100, categoryName=达仁堂循证e学界, tenant=100)], articleKeywordId=0, articleKeyword=, articleKeywordNum=6, guiderKeywordId=441, guiderKeyword=哮喘, guiderKeywordNum=6, haveAttachments=1, attachmentList=null, guiderType=0, guiderArea=共识, guiderLanguage=1, guiderRegion=4, opened=0, paymentType=, paymentAmount=10, recommend=0, recommendEndTime=null, sticky=0, stickyEndTime=null, allHits=2554, appHits=340, showAppHits=0, pcHits=421, showPcHits=2203, likes=1, shares=32, comments=23, approvalStatus=1, publishedTime=Thu Nov 26 00:27:03 CST 2020, publishedTimeString=2020-11-10, pcVisible=1, appVisible=1, editorId=2020535, editor=qiushida2, waterMark=0, formatted=0, memberCards=[], isPrivilege=0, deleted=0, version=2, createdBy=null, createdName=qiushida2, createdTime=Thu Nov 26 00:26:50 CST 2020, updatedBy=2020535, updatedName=qiushida2, updatedTime=Wed Jan 03 09:05:55 CST 2024, courseDetails=[], otherVersionGuiders=[], isGuiderMember=false, ipAttribution=, attachmentFileNameList=[AttachmentFileName(sort=1, fileName=2020 多学科共识:哮喘的吸入治疗.pdf)])
2020 多学科共识:哮喘的吸入治疗.pdf
下载请点击:
评论区 (16)
#插入话题
  1. [GetPortalCommentsPageByObjectIdResponse(id=1190606, encodeId=247c119060695, content=有用, beContent=null, objectType=guider, channel=null, level=null, likeNumber=43, replyNumber=0, topicName=null, topicId=null, topicList=[], attachment=null, authenticateStatus=null, createdAvatar=null, createdBy=7e8d5491365, createdName=ms7000001162275972, createdTime=Sun Feb 06 22:57:07 CST 2022, time=2022-02-06, status=1, ipAttribution=), GetPortalCommentsPageByObjectIdResponse(id=968452, encodeId=f051968452ad, content=学习, beContent=null, objectType=guider, channel=null, level=null, likeNumber=60, replyNumber=0, topicName=null, topicId=null, topicList=[], attachment=null, authenticateStatus=null, createdAvatar=null, createdBy=79085507707, createdName=ms5000001479087297, createdTime=Tue May 25 20:47:45 CST 2021, time=2021-05-25, status=1, ipAttribution=), GetPortalCommentsPageByObjectIdResponse(id=959111, encodeId=47b29591118f, content=学习, beContent=null, objectType=guider, channel=null, level=null, likeNumber=46, replyNumber=0, topicName=null, topicId=null, topicList=[], attachment=null, authenticateStatus=null, createdAvatar=null, createdBy=7cf65483902, createdName=ms7000000587907369, createdTime=Wed Apr 21 17:21:35 CST 2021, time=2021-04-21, status=1, ipAttribution=), GetPortalCommentsPageByObjectIdResponse(id=952620, encodeId=c408952620b1, content=学习, beContent=null, objectType=guider, channel=null, level=null, likeNumber=57, replyNumber=0, topicName=null, topicId=null, topicList=[], attachment=null, authenticateStatus=null, createdAvatar=null, createdBy=6bb95475014, createdName=ms8000000479428574, createdTime=Wed Mar 31 13:25:49 CST 2021, time=2021-03-31, status=1, ipAttribution=), GetPortalCommentsPageByObjectIdResponse(id=949002, encodeId=41ef94900291, content=求积分,学习学习, beContent=null, objectType=guider, channel=null, level=null, likeNumber=64, replyNumber=0, topicName=null, topicId=null, topicList=[], attachment=null, authenticateStatus=null, createdAvatar=https://img.medsci.cn/20210706/fed1c69edef040aa845e61835a8d1382/53e965c9bdde4992a6e934a143e0aef7.jpg, createdBy=686b5468799, createdName=ms8000001914536834, createdTime=Wed Mar 17 16:26:05 CST 2021, time=2021-03-17, status=1, ipAttribution=)]
    2022-02-06 ms7000001162275972

    有用

    0

  2. [GetPortalCommentsPageByObjectIdResponse(id=1190606, encodeId=247c119060695, content=有用, beContent=null, objectType=guider, channel=null, level=null, likeNumber=43, replyNumber=0, topicName=null, topicId=null, topicList=[], attachment=null, authenticateStatus=null, createdAvatar=null, createdBy=7e8d5491365, createdName=ms7000001162275972, createdTime=Sun Feb 06 22:57:07 CST 2022, time=2022-02-06, status=1, ipAttribution=), GetPortalCommentsPageByObjectIdResponse(id=968452, encodeId=f051968452ad, content=学习, beContent=null, objectType=guider, channel=null, level=null, likeNumber=60, replyNumber=0, topicName=null, topicId=null, topicList=[], attachment=null, authenticateStatus=null, createdAvatar=null, createdBy=79085507707, createdName=ms5000001479087297, createdTime=Tue May 25 20:47:45 CST 2021, time=2021-05-25, status=1, ipAttribution=), GetPortalCommentsPageByObjectIdResponse(id=959111, encodeId=47b29591118f, content=学习, beContent=null, objectType=guider, channel=null, level=null, likeNumber=46, replyNumber=0, topicName=null, topicId=null, topicList=[], attachment=null, authenticateStatus=null, createdAvatar=null, createdBy=7cf65483902, createdName=ms7000000587907369, createdTime=Wed Apr 21 17:21:35 CST 2021, time=2021-04-21, status=1, ipAttribution=), GetPortalCommentsPageByObjectIdResponse(id=952620, encodeId=c408952620b1, content=学习, beContent=null, objectType=guider, channel=null, level=null, likeNumber=57, replyNumber=0, topicName=null, topicId=null, topicList=[], attachment=null, authenticateStatus=null, createdAvatar=null, createdBy=6bb95475014, createdName=ms8000000479428574, createdTime=Wed Mar 31 13:25:49 CST 2021, time=2021-03-31, status=1, ipAttribution=), GetPortalCommentsPageByObjectIdResponse(id=949002, encodeId=41ef94900291, content=求积分,学习学习, beContent=null, objectType=guider, channel=null, level=null, likeNumber=64, replyNumber=0, topicName=null, topicId=null, topicList=[], attachment=null, authenticateStatus=null, createdAvatar=https://img.medsci.cn/20210706/fed1c69edef040aa845e61835a8d1382/53e965c9bdde4992a6e934a143e0aef7.jpg, createdBy=686b5468799, createdName=ms8000001914536834, createdTime=Wed Mar 17 16:26:05 CST 2021, time=2021-03-17, status=1, ipAttribution=)]
    2021-05-25 ms5000001479087297

    学习

    0

  3. [GetPortalCommentsPageByObjectIdResponse(id=1190606, encodeId=247c119060695, content=有用, beContent=null, objectType=guider, channel=null, level=null, likeNumber=43, replyNumber=0, topicName=null, topicId=null, topicList=[], attachment=null, authenticateStatus=null, createdAvatar=null, createdBy=7e8d5491365, createdName=ms7000001162275972, createdTime=Sun Feb 06 22:57:07 CST 2022, time=2022-02-06, status=1, ipAttribution=), GetPortalCommentsPageByObjectIdResponse(id=968452, encodeId=f051968452ad, content=学习, beContent=null, objectType=guider, channel=null, level=null, likeNumber=60, replyNumber=0, topicName=null, topicId=null, topicList=[], attachment=null, authenticateStatus=null, createdAvatar=null, createdBy=79085507707, createdName=ms5000001479087297, createdTime=Tue May 25 20:47:45 CST 2021, time=2021-05-25, status=1, ipAttribution=), GetPortalCommentsPageByObjectIdResponse(id=959111, encodeId=47b29591118f, content=学习, beContent=null, objectType=guider, channel=null, level=null, likeNumber=46, replyNumber=0, topicName=null, topicId=null, topicList=[], attachment=null, authenticateStatus=null, createdAvatar=null, createdBy=7cf65483902, createdName=ms7000000587907369, createdTime=Wed Apr 21 17:21:35 CST 2021, time=2021-04-21, status=1, ipAttribution=), GetPortalCommentsPageByObjectIdResponse(id=952620, encodeId=c408952620b1, content=学习, beContent=null, objectType=guider, channel=null, level=null, likeNumber=57, replyNumber=0, topicName=null, topicId=null, topicList=[], attachment=null, authenticateStatus=null, createdAvatar=null, createdBy=6bb95475014, createdName=ms8000000479428574, createdTime=Wed Mar 31 13:25:49 CST 2021, time=2021-03-31, status=1, ipAttribution=), GetPortalCommentsPageByObjectIdResponse(id=949002, encodeId=41ef94900291, content=求积分,学习学习, beContent=null, objectType=guider, channel=null, level=null, likeNumber=64, replyNumber=0, topicName=null, topicId=null, topicList=[], attachment=null, authenticateStatus=null, createdAvatar=https://img.medsci.cn/20210706/fed1c69edef040aa845e61835a8d1382/53e965c9bdde4992a6e934a143e0aef7.jpg, createdBy=686b5468799, createdName=ms8000001914536834, createdTime=Wed Mar 17 16:26:05 CST 2021, time=2021-03-17, status=1, ipAttribution=)]
    2021-04-21 ms7000000587907369

    学习

    0

  4. [GetPortalCommentsPageByObjectIdResponse(id=1190606, encodeId=247c119060695, content=有用, beContent=null, objectType=guider, channel=null, level=null, likeNumber=43, replyNumber=0, topicName=null, topicId=null, topicList=[], attachment=null, authenticateStatus=null, createdAvatar=null, createdBy=7e8d5491365, createdName=ms7000001162275972, createdTime=Sun Feb 06 22:57:07 CST 2022, time=2022-02-06, status=1, ipAttribution=), GetPortalCommentsPageByObjectIdResponse(id=968452, encodeId=f051968452ad, content=学习, beContent=null, objectType=guider, channel=null, level=null, likeNumber=60, replyNumber=0, topicName=null, topicId=null, topicList=[], attachment=null, authenticateStatus=null, createdAvatar=null, createdBy=79085507707, createdName=ms5000001479087297, createdTime=Tue May 25 20:47:45 CST 2021, time=2021-05-25, status=1, ipAttribution=), GetPortalCommentsPageByObjectIdResponse(id=959111, encodeId=47b29591118f, content=学习, beContent=null, objectType=guider, channel=null, level=null, likeNumber=46, replyNumber=0, topicName=null, topicId=null, topicList=[], attachment=null, authenticateStatus=null, createdAvatar=null, createdBy=7cf65483902, createdName=ms7000000587907369, createdTime=Wed Apr 21 17:21:35 CST 2021, time=2021-04-21, status=1, ipAttribution=), GetPortalCommentsPageByObjectIdResponse(id=952620, encodeId=c408952620b1, content=学习, beContent=null, objectType=guider, channel=null, level=null, likeNumber=57, replyNumber=0, topicName=null, topicId=null, topicList=[], attachment=null, authenticateStatus=null, createdAvatar=null, createdBy=6bb95475014, createdName=ms8000000479428574, createdTime=Wed Mar 31 13:25:49 CST 2021, time=2021-03-31, status=1, ipAttribution=), GetPortalCommentsPageByObjectIdResponse(id=949002, encodeId=41ef94900291, content=求积分,学习学习, beContent=null, objectType=guider, channel=null, level=null, likeNumber=64, replyNumber=0, topicName=null, topicId=null, topicList=[], attachment=null, authenticateStatus=null, createdAvatar=https://img.medsci.cn/20210706/fed1c69edef040aa845e61835a8d1382/53e965c9bdde4992a6e934a143e0aef7.jpg, createdBy=686b5468799, createdName=ms8000001914536834, createdTime=Wed Mar 17 16:26:05 CST 2021, time=2021-03-17, status=1, ipAttribution=)]
    2021-03-31 ms8000000479428574

    学习

    0

  5. [GetPortalCommentsPageByObjectIdResponse(id=1190606, encodeId=247c119060695, content=有用, beContent=null, objectType=guider, channel=null, level=null, likeNumber=43, replyNumber=0, topicName=null, topicId=null, topicList=[], attachment=null, authenticateStatus=null, createdAvatar=null, createdBy=7e8d5491365, createdName=ms7000001162275972, createdTime=Sun Feb 06 22:57:07 CST 2022, time=2022-02-06, status=1, ipAttribution=), GetPortalCommentsPageByObjectIdResponse(id=968452, encodeId=f051968452ad, content=学习, beContent=null, objectType=guider, channel=null, level=null, likeNumber=60, replyNumber=0, topicName=null, topicId=null, topicList=[], attachment=null, authenticateStatus=null, createdAvatar=null, createdBy=79085507707, createdName=ms5000001479087297, createdTime=Tue May 25 20:47:45 CST 2021, time=2021-05-25, status=1, ipAttribution=), GetPortalCommentsPageByObjectIdResponse(id=959111, encodeId=47b29591118f, content=学习, beContent=null, objectType=guider, channel=null, level=null, likeNumber=46, replyNumber=0, topicName=null, topicId=null, topicList=[], attachment=null, authenticateStatus=null, createdAvatar=null, createdBy=7cf65483902, createdName=ms7000000587907369, createdTime=Wed Apr 21 17:21:35 CST 2021, time=2021-04-21, status=1, ipAttribution=), GetPortalCommentsPageByObjectIdResponse(id=952620, encodeId=c408952620b1, content=学习, beContent=null, objectType=guider, channel=null, level=null, likeNumber=57, replyNumber=0, topicName=null, topicId=null, topicList=[], attachment=null, authenticateStatus=null, createdAvatar=null, createdBy=6bb95475014, createdName=ms8000000479428574, createdTime=Wed Mar 31 13:25:49 CST 2021, time=2021-03-31, status=1, ipAttribution=), GetPortalCommentsPageByObjectIdResponse(id=949002, encodeId=41ef94900291, content=求积分,学习学习, beContent=null, objectType=guider, channel=null, level=null, likeNumber=64, replyNumber=0, topicName=null, topicId=null, topicList=[], attachment=null, authenticateStatus=null, createdAvatar=https://img.medsci.cn/20210706/fed1c69edef040aa845e61835a8d1382/53e965c9bdde4992a6e934a143e0aef7.jpg, createdBy=686b5468799, createdName=ms8000001914536834, createdTime=Wed Mar 17 16:26:05 CST 2021, time=2021-03-17, status=1, ipAttribution=)]
    2021-03-17 ms8000001914536834

    求积分,学习学习

    0

拓展阅读

2009 NICE儿童慢性哮喘管理指南 - 2009更新

英国国家卫生与临床优化研究所(NICE,National Institute for Health and Clinical Excellence) · 2009-12-01

2009 SACAWG儿童慢性哮喘管理指南(更新版)

南非儿童哮喘工作组(SACAWG,South African Childhood Asthma Working Group) · 2009-12-20

2010 GINA 全球哮喘处理和预防策略

全球哮喘防治创议(GINA,Global INitiative for Asthma) · 2010-01-01

2010CTS 年共识,总结六岁及以上的儿童和成人哮喘的管理指南

加拿大胸科学会(CTS,Canadian Thoracic Society) · 2010-01-01

2010BC 哮喘-诊断和管理

英国哥伦比亚临床实践指南中心(BC,Clinical Practice Guidelines and Protocols in British Columbia) · 2010-01-01

2010NAC在儿童哮喘管理的白三烯受体拮抗剂

澳大利亚国家哮喘委员会(NAC,National Asthma Council (Australia)) · 2010-01-01